John B. Henneman, III
2016 - NewLink Genetics
In 2016, John B. Henneman, III earned a total compensation of $3.6M as Chief Financial Officer & Secretary at NewLink Genetics, a 342% increase compared to previous year.
Compensation breakdown
| Bonus | $26,250 |
|---|---|
| Non-Equity Incentive Plan | $84,720 |
| Option Awards | $2,153,813 |
| Salary | $423,600 |
| Stock Awards | $903,675 |
| Other | $26,729 |
| Total | $3,618,787 |
Henneman received $2.2M in option awards, accounting for 60% of the total pay in 2016.
Henneman also received $26.3K in bonus, $84.7K in non-equity incentive plan, $423.6K in salary, $903.7K in stock awards and $26.7K in other compensation.
Rankings
In 2016, John B. Henneman, III's compensation ranked 2,539th out of 14,075 executives tracked by ExecPay. In other words, Henneman earned more than 82.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,539 out of 14,075 | 82nd |
Division Manufacturing | 872 out of 5,489 | 84th |
Major group Chemicals And Allied Products | 254 out of 1,895 | 87th |
Industry group Drugs | 183 out of 1,538 | 88th |
Industry Pharmaceutical Preparations | 140 out of 1,176 | 88th |
Source: SEC filing on March 31, 2017.
Henneman's colleagues
We found five more compensation records of executives who worked with John B. Henneman, III at NewLink Genetics in 2016.
2016
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2016
Nicholas Vahanian
NewLink Genetics
Chief Medical Officer
2016
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2016
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2016
Carl Langren
NewLink Genetics